Skip to main content
. 2022 Jul 15;13:896958. doi: 10.3389/fimmu.2022.896958

Table 3.

The results of the mRNA vaccine safety assessment.

Both mRNA vaccines (n=340522) BNT162b2 vaccine (n=164669) mRNA-1273 vaccine (n=175816)
Non-serious 313499 (92.1%) 150486 (91.4%) 162977 (92.7%)
Serious, including death 27023 (7.9%) 14183 (8.6%) 12839 (7.3%)
Serious, excluding death 22527 (6.6%) 12078 (7.3%) 10448 (5.9%)
Death 4496 (1.3%) 2105 (1.3%) 2391 (1.4%)